Life Sciences Partner Quoted in Scrip Regulatory Affairs on China’s New Rules on Clinical Trials

In The News
November 6, 2014

Life sciences partner Katherine Wang (Shanghai) was quoted extensively in an article titled “Medtech and pharma: heed stricter China clinical trial rules for hospitals” appearing in Scrip Regulatory Affairs on Oct. 31, 2014.  In the article, Ms. Wang discusses the new NHPFC rules for medical institutions conducting clinical trials in China that became effective in October and suggests that medical device and drug companies should review their internal policies in light of the new measures.  

To read the article, click here